logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

AUPH
Aurinia Pharmaceuticals Inc.
15.80
1 x 13.91
1 x 18.30
bid
ask
-
1.17
6.89%
1 @ 05:36 AM
15.88 +0.08 (0.51%)
Ytd-0.94%
1y111.23%
15.78
day range
17.12
7.29
52 week range
19.25
Open16.97Prev Close16.97Low15.78High17.12Mkt Cap2.03B
Vol2.02MAvg Vol1.41MEPS2.16P/E7.31Forward P/E14.13
Beta1.43Short Ratio7.72Inst. Own60.26%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-3050-d Avg15.99200-d Avg14.781yr Est17.00

AUPH News

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
zacks.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker

Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook art

5 Small Drug Stocks to Invest in Amid a Biotech Comeback
zacks.com
5 Small Drug Stocks to Invest in Amid a Biotech Comeback

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may pr

10 Health Care Stocks Whale Activity In Today's Session
benzinga.com
10 Health Care Stocks Whale Activity In Today's Session

benzinga.com
Aurinia Pharmaceuticals' New Analysis Of Aurora 1 Phase 3 Study Of Lupkynis For Lupus Nephritis Show

Hazard ratios (HRs) favored treatment with LUPKYNIS for the following individual components of the c

benzinga.com
Tang Capital Raises Aurinia Pharmaceuticals Holding to 10%

Tang Capital Management, LLC announces that on June 2, 2026, it acquired 206,005 common shares (the